CRIS Current Research Information System

RIZZELLO, FERNANDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.422
AS - Asia 7.559
EU - Europa 7.120
AF - Africa 696
SA - Sud America 591
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 9
Totale 26.412
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.271
SG - Singapore 2.422
CN - Cina 2.205
GB - Regno Unito 1.591
IT - Italia 1.569
VN - Vietnam 1.266
DE - Germania 910
SE - Svezia 780
HK - Hong Kong 663
BR - Brasile 435
IN - India 407
RU - Federazione Russa 404
UA - Ucraina 344
FR - Francia 327
IE - Irlanda 294
NL - Olanda 207
KR - Corea 188
CI - Costa d'Avorio 183
SC - Seychelles 158
TG - Togo 154
ZA - Sudafrica 147
FI - Finlandia 121
CH - Svizzera 111
BG - Bulgaria 109
EE - Estonia 108
JP - Giappone 108
JO - Giordania 104
AR - Argentina 79
BE - Belgio 63
CA - Canada 52
ID - Indonesia 45
PL - Polonia 40
HN - Honduras 37
AT - Austria 33
ES - Italia 32
MX - Messico 32
GR - Grecia 23
NG - Nigeria 20
IR - Iran 19
EC - Ecuador 18
BZ - Belize 17
CL - Cile 17
TR - Turchia 17
BD - Bangladesh 16
UZ - Uzbekistan 16
CO - Colombia 14
PY - Paraguay 14
IQ - Iraq 13
AU - Australia 12
CZ - Repubblica Ceca 12
LT - Lituania 11
MY - Malesia 8
PH - Filippine 8
PK - Pakistan 8
RO - Romania 8
LB - Libano 7
PT - Portogallo 7
TW - Taiwan 7
SA - Arabia Saudita 6
EG - Egitto 5
EU - Europa 5
KE - Kenya 5
AZ - Azerbaigian 4
BO - Bolivia 4
HR - Croazia 4
IL - Israele 4
KZ - Kazakistan 4
MA - Marocco 4
PE - Perù 4
TN - Tunisia 4
VE - Venezuela 4
A2 - ???statistics.table.value.countryCode.A2??? 3
DZ - Algeria 3
TT - Trinidad e Tobago 3
AE - Emirati Arabi Uniti 2
BW - Botswana 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GD - Grenada 2
JM - Giamaica 2
LA - Repubblica Popolare Democratica del Laos 2
MU - Mauritius 2
NO - Norvegia 2
QA - Qatar 2
RS - Serbia 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AO - Angola 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CG - Congo 1
GA - Gabon 1
GT - Guatemala 1
HU - Ungheria 1
KH - Cambogia 1
KW - Kuwait 1
LK - Sri Lanka 1
LV - Lettonia 1
Totale 26.396
Salva come PNG Salva come JPEG
Città #
Singapore 1.584
Southend 1.351
Ashburn 1.213
Fairfield 1.054
Chandler 835
Hong Kong 654
Woodbridge 530
Santa Clara 500
Houston 489
Hefei 478
Wilmington 459
Seattle 431
Princeton 385
Beijing 354
Cambridge 346
Dong Ket 326
Ann Arbor 325
Bologna 313
Dublin 294
Boardman 241
Ho Chi Minh City 216
Abidjan 183
Seoul 176
Jacksonville 174
Nanjing 168
Hanoi 164
Lomé 154
Westminster 148
Padova 123
Berlin 122
New York 120
Los Angeles 117
Milan 110
Sofia 108
Amman 104
San Diego 99
Tokyo 99
Buffalo 94
Bern 92
Helsinki 91
Dallas 84
Frankfurt am Main 78
Turin 74
Shenyang 72
Redondo Beach 71
Jinan 69
Saint Petersburg 66
Rome 65
Munich 56
Changsha 55
Bengaluru 51
Guangzhou 51
Phoenix 51
Hebei 50
Brussels 44
Redwood City 44
São Paulo 44
Mülheim 43
Medford 41
Redmond 39
Shanghai 36
Bremen 35
Nanchang 35
Yubileyny 34
Dearborn 33
Florence 33
Henderson 33
Des Moines 32
Nuremberg 31
Tianjin 30
Falkenstein 28
Saint Louis 27
Centro 26
Falls Church 26
Jiaxing 26
Chicago 25
London 25
Zhengzhou 25
Haiphong 24
Mahé 24
Atlanta 23
Norwalk 23
Washington 22
Brierley Hill 21
Haikou 20
Hangzhou 20
Jakarta 20
Amsterdam 19
Brooklyn 19
Johannesburg 19
Rio de Janeiro 19
Taiyuan 19
Olalla 18
Orem 18
Bitonto 17
Boydton 17
Modena 17
Piove di Sacco 17
Pune 17
San Francisco 17
Totale 16.942
Salva come PNG Salva come JPEG
Nome #
Refractory Complex Crohn's Perianal Fistulas: A Role for Autologous Microfragmented Adipose Tissue Injection 581
Ulcerative Colitis 316
Human cord blood-derived platelet lysate enhances the therapeutic activity of adipose-derived mesenchymal stromal cells isolated from Crohn's disease patients in a mouse model of colitis 284
Dietary geraniol ameliorates intestinal dysbiosis and relieves symptoms in irritable bowel syndrome patients: a pilot study. 282
COVID-19 in IBD: The experience of a single tertiary IBD center 261
Management of pouch dysfunction or pouchitis with an ileoanal pouch. 220
A-Transducin, a Signaling Molecule of the Chemoreceptive Cascade, Is Expressed in Endocrine and Non-Endocrine Cells of the Pig Gastrointestinal Mucosa 215
Adult attachment and early parental experiences in patients with Crohn’s Disease 212
Absence of change in the gray matter volume of patients with ulcerative colitis in remission: a voxel based morphometry study 207
Four cases of carcinoid tumour in Crohn's disease: coincidence or correlation? 206
Can supplementation of phytoestrogens/insoluble fibers help the management of duodenal polyps in familial adenomatous polyposis? 205
Adalimumab in active ulcerative colitis: a "real-life" observational study. 203
A Heavy Feeling in the Stomach: Neural Correlates of Anxiety in Crohn's Disease 198
Dietary geraniol by oral or enema administration strongly reduces dysbiosis and systemic inflammation in dextran sulfate sodium-treated mice 196
Infliximab in the treatment of Crohn's disease 194
Attachment and quality of life in patients with inflammatory bowel disease 189
Medical treatment and management of severe ulcerative colitis 187
Cell proliferation of esophageal squamous epithelium in erosive and non-erosive reflux disease 187
Cyclooxygenase-2 Silencing for the Treatment of Colitis: A Combined In Vivo Strategy Based on RNA Interference and Engineered Escherichia Coli 185
Clinical management of severe active ulcerative colitis in the TNF-α inhibitors era 184
MODULATION OF HUMAN DENDRITIC CELL PHENOTYPE AND FUNCTION BY PROBIOTIC BACTERIA 183
High-dose probiotics for the treatment of active pouchitis 183
Performance of Capsule Endoscopy and Cross-Sectional Techniques in Detecting Small Bowel Lesions in Patients with Crohn’s Disease 183
Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis 182
Effectiveness of swapping to ustekinumab after vedolizumab failure in patients with multi-refractory Crohn's disease 180
Short-term treatment with Infliximab in chronic refractory pouchitis and ileitis. 179
Real-time elastography for the detection of fibrotic and inflammatory tissue in patients with stricturing Crohn's disease 179
Brain functional changes in patients with ulcerative colitis: a functional magnetic resonance imaging study on emotional processing 176
Distinct proteomic profiles characterise non-erosive from erosive reflux disease. 173
Adalimumab in the Treatment of Perianal Crohn's Disease: A Single Center in 64 Patients 173
Clinical course of microscopic colitis in a single-center cohort study 173
Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. 172
Cutaneous Manifestations in Inflammatory Bowel Diseases: Eight Cases of Psoriasis Induced by Anti-Tumor-Necrosis-Factor Antibody Therapy 171
ADALIMUMAB IN THE TREATMENT OF PERIANAL CROHN'S DISEASE: A SINGLE CENTER EXPERIENCE IN 64 PATIENTS 170
Infliximab in the treatment of Crohn's disease: predictors of response in an Italian multicentric open study 169
Management and treatment of distal ulcerative colitis 168
Functional magnetic resonance imaging study reveals differences in the habituation to psychological stress in patients with Crohn's disease versus healthy controls 166
Percutaneous Drainage vs. Surgery as Definitive Treatment for Anastomotic Leak after Intestinal Resection in Patients with Crohn's Disease 165
3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 1: Diagnosis and Medical Management 165
Prevalence and effectiveness of psychiatric treatments for patients with IBD: A systematic literature review 165
Drug delivery by polymeric micelles: an in vitro and in vivo study to deliver lipophilic substances to colonocytes and selectively target inflamed colon 164
Potential role of the cannabinoid receptor CB in the pathogenesis of erosive and non-erosive gastro-oesophageal reflux disease 164
Ninety-six-hour wireless oesophageal pH monitoring following proton pump inhibitor administration in NERD patients. 164
Antibiotics and probiotics in treatment of inflammatory bowel disease 163
Implications of antioxidant enzymes in human gastric neoplasms 161
Oral budesonide in the treatment of chronic refractory pouchitis. 160
ADALIMUMAB IN THE TREATMENT OF PERIANAL CROHN'S DISEASE: LONG TERM RESULTS IN A SINGLE TERTIARY CENTRE 160
Controlled study using wireless capsule endoscopy for the evaluation of the small intestine in chronic refractory pouchitis 160
Review article: aminosalicylates for distal colitis 156
Geraniol Treatment for Irritable Bowel Syndrome: A Double-Blind Randomized Clinical Trial 155
P151 Characteristics of presentation and risk factors for early recurrence after strictureplasty for Crohn’s disease of the small bowel in the biological era 154
Adalimumab Clearance, rather than Trough Level, May Have Greatest Relevance to Crohn's Disease Therapeutic Outcomes Assessed Clinically and Endoscopically 153
Management of inflammatory bowel disease: does rifaximin offer any promises 153
COMBINATION OF SURGICAL THERAPY AND LOCAL INJECTIONS OF ADALIMUMAB IN TREATEMENT OF COMPLEX PERIANAL CROHN'S DISEASE 153
Probiotics, Prebiotics and Antibiotics in the Treatment of Inflammatory Bowel Disease 153
Differential Brain Structural and Functional Patterns in Crohn's Disease Patients are Associated with Different Disease Stages 152
Which therapies are advisable in pouchitis? 151
Role of Biologics in refractory pouchitis 151
Role of conventional therapies in the era of biological treatment in Crohn's disease. 151
Probiotics in IBD: A critical review 151
Loss of miR-101 expression promotes Wnt/β-catenin signalling pathway activation and malignancy in colon cancer cells 150
Antimicrobials in the management of inflammatory bowel disease 150
Parental Bonding and Inflammatory Bowel Disease 150
Interaction of probiotic Lactobacillus and Bifidobacterium strains with human intestinal epithelial cells: adhesion properties, competition against enteropathogens and modulation of IL-8 production 149
The role of Budesonide-MMX in active ulcerative colitis. 149
MANAGEMENT OF POUCHITIS 149
Medical Treatment of Ulcerative Colitis: does traditional therapy still have a role? 148
Sympathetic hyperactivity in patients with ulcerative colitis. 145
Randomized controlled trials in pouchitis 145
Transabdominal salvage surgery after pouch failure in a tertiary center: a case-matched study 145
P325 Risk factors for lymph node involvement in patients undergoing ileal pouch-anal anastomosis for ulcerative colitis complicated by colorectal cancer in the biological years 144
Local Injection of Infliximab for the Treatment of Perianal Crohn's Disease. 144
Pre-pouch ileitis 143
Sporadic small bowel tumors detected by capsule endoscopy in patients with occult gastrointestinal bleeding 143
Problematic proctitis and distal colitis 143
New insights into the brain involvement in patients with Crohn's disease: a voxel-based morphometry study 142
Local injection of adalimumab for perianal Crohn's disease: better than infliximab? 142
Combined carriership of TLR9-1237C and CD14-260T alleles enhances the risk of developing chronic relapsing pouchitis 141
Probiotics, Prebiotics, and Antibiotics in IBD 140
Comparison of intestinal ultrasound, conventional enteroclysis, CT and MRI enteroclysis, surgical findings for determining complications in patients with Crohn's Disease 140
Topical treatment of distal active ulcerative colitis with beclometasone dipropionato or mesalamine: a single-blind randomized controlled trial 139
OC.01.8 USE OF INFLIXIMAB AND ADALIMUMAB IN REFRACTORY POUCHITIS 139
CT-guided percutaneous pelvic abscess drainage in Crohn's disease 139
Systematic review with meta-analysis: Diagnostic performance of faecal calprotectin in distinguishing inflammatory bowel disease from irritable bowel syndrome in adults 138
Oral beclomethasone dipropionate in chronic refractory pouchitis 138
Obscure gastrointestinal bleeding: single centre experience of capsule endoscopy. 138
Platelet lysate enhances the therapeutic activity of Adipose Derived Mesenchymal stromal cells isolated from Crohn disease patients in a novel Mouse model of Colitis 138
Selective cyclooxygenase-2 (COX-2) silencing mediated by engineered Escherichia coli and RNA Interference induces anti-tumour effects in human colon cancer cells 137
Implications of the westernized diet in the onset and progression of IBD 137
Dietary Habits and Nutrient Deficiencies in a Cohort of European Crohn's Disease Adult Patients 137
Nutritional Biomarkers for the Prediction of Response to Anti-TNF-α Therapy in Crohn's Disease: New Tools for New Approaches 136
A current overview of corticosteroid use in active ulcerative colitis 135
Percutaneous abdomino-pelvic abscess drainage in complicated Crohn’s disease 135
The role of antibiotics and probiotics in pouchitis 133
Eviendep® reduces number and size of duodenal polyps in familial adenomatous polyposis patients with ileal pouch-anal anastomosis 133
Multidisciplinary Management of Spondyloarthritis-Related Immune-Mediated Inflammatory Disease 133
Predictors of early recurrence after strictureplasty for Crohn's disease of the small bowel during the years of biologics 131
Case-control Study on Dactylitis, Enthesitis, and Anterior Uveitis in Spondyloarthritis Associated with Inflammatory Bowel Diseases: Role of Coexistent Psoriasis 130
Rescue therapy: ciclosporin or infliximab? 129
Probiotic therapy to prevent pouchitis onset 129
Totale 16.922
Salva come PNG Salva come JPEG
Categoria #
all - tutte 80.032
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 80.032
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.877 0 0 0 0 0 150 124 248 297 220 96 742
2021/20223.313 352 93 217 160 295 168 83 194 202 236 817 496
2022/20233.789 396 510 184 460 247 316 102 209 736 104 269 256
2023/20241.219 80 199 109 92 95 290 73 76 35 65 46 59
2024/20254.588 248 686 388 291 720 225 284 160 108 339 215 924
2025/20265.787 1.021 1.124 966 830 1.239 607 0 0 0 0 0 0
Totale 27.158